PACLX
Price
$37.45
Change
-$0.21 (-0.56%)
Updated
Jul 13 closing price
Net Assets
71.29B
RPBAX
Price
$29.74
Change
-$0.19 (-0.63%)
Updated
Jul 13 closing price
Net Assets
5.29B
Interact to see
Advertisement

PACLX vs RPBAX

PACLX vs RPBAX Comparison Chart in %
View a ticker or compare two or three
VS
PACLX vs. RPBAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACLX is a StrongBuy and RPBAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PACLX has more cash in the bank: 71.3B vs. RPBAX (5.29B). RPBAX pays higher dividends than PACLX: RPBAX (2.02) vs PACLX (1.49). PACLX was incepted earlier than RPBAX: PACLX (22 years) vs RPBAX (87 years). PACLX (1.01) is less costly to investors than RPBAX (0.66). PACLX is a more actively managed with annual turnover of: 124.70 vs. RPBAX (43.70). PACLX (2500) and RPBAX (2500) have matching initial minimum investment requirements. RPBAX annual gain was more profitable for investors over the last year : 9.04 vs. PACLX (5.27). RPBAX return over 5 years is better than : 11.41 vs. PACLX (7.91).
PACLXRPBAXPACLX / RPBAX
Total Expense Ratio0.980.61161%
Annual Report Gross Expense Ratio1.010.66153%
Fund Existence22 years87 years-
Gain YTD7.3556.565112%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets71.3B5.29B1,348%
Annual Yield % from dividends1.492.0274%
Returns for 1 year5.279.0458%
Returns for 3 years20.6729.4570%
Returns for 5 years7.9111.4169%
Returns for 10 years61.3861.56100%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OSRH0.360.03
+8.40%
OSR Health Inc
INHD39.49N/A
N/A
Inno Holdings Inc.
UCB35.54-0.01
-0.03%
United Community Banks Inc
ALNY288.06-10.70
-3.58%
Alnylam Pharmaceuticals
AVR9.36-0.41
-4.20%
Anteris Technologies Global Corp